Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFα antagonists.
A cell-based assay has been developed for the quantification of the activity of TNFα antagonists based on human erythroleukemic K562 cells transfected with a NFκB regulated firefly luciferase reporter-gene construct. Both drug activity and anti-drug neutralizing antibodies can be quantified with a h...
Main Authors: | Lallemand, C, Kavrochorianou, N, Steenholdt, C, Bendtzen, K, Ainsworth, M, Meritet, J, Blanchard, B, Lebon, P, Taylor, P, Charles, P, Alzabin, S, Tovey, MG |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Immunogenicity of anti-TNF-α biotherapies.I. Individualized medicine based on immunopharmacological evidence
by: Klaus eBendtzen
Published: (2015-04-01) -
Xplore® mRNA Assays for the Quantification of IL-1β and TNF-α mRNA in Lipopolysaccharide-Induced Mouse Macrophages
by: S.W. Van Arsdell, et al.
Published: (2000-06-01) -
Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
by: Kyle J. Brymer, et al.
Published: (2019-02-01) -
Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
by: Ilaria Sauzullo, et al.
Published: (2010-06-01) -
The Effect of TNF-α on CHD and the Relationship between TNF-α Antagonist and CHD in Rheumatoid Arthritis: A Systematic Review
by: Yezhou Qian, et al.
Published: (2022-01-01)